Ind-Swift Laboratories Limited
INDSWFTLAB.BO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$28.48B
Close$
$12.73
96.6% downside
Current Fair Value
96.6% downsideOvervalued by 96.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $28.48 Billion |
|---|---|
| Enterprise Value | $28.48 Billion |
| Earnings per Share | $4.95 |
| Beta | 0.58 |
| Outstanding Shares | 86,836,600 |
Return
| Return on Equity | 4.14% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 48.01 |
|---|---|
| PEG | 26.48 |
| Price to Sales | 4.99 |
| Price to Book Ratio | 2.39 |
| Enterprise Value to Revenue | 4.28 |
| Enterprise Value to EBIT | 62.22 |
| Enterprise Value to Net Income | 49 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Ind-Swift Laboratories Limited
1,388 employees
CEO: Navrattan R. Munjal
Established in 1995 and headquartered in Manimajra, India, Ind-Swift Laboratories Limited is an Indian pharmaceutical company primarily focused on the creation, production, and commercialization of active pharmaceutical ingredients (APIs...